| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) | 
|---|
| 06/16/1999 | EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives  | 
| 06/16/1999 | EP0827507B1 Protease inhibiting succinic acid derivatives  | 
| 06/16/1999 | CN1219926A Phenylthanolaminotetralin carboxamide derivatives  | 
| 06/15/1999 | US5912387 Amine heat stable salt neutralization having reduced solids  | 
| 06/15/1999 | US5912360 Dioxolane intermediates  | 
| 06/15/1999 | US5912350 Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands  | 
| 06/15/1999 | US5911970 Antitumor agents and anticarcinogenic agents  | 
| 06/10/1999 | WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride  | 
| 06/10/1999 | WO1999027937A2 Method for inhibiting cytokine production by cells  | 
| 06/10/1999 | CA2312023A1 Method for inhibiting cytokine production by cells  | 
| 06/09/1999 | EP0921117A2 Acylguanidines  | 
| 06/09/1999 | EP0921116A1 N-(4-carbamimido-phenyl)-glycine amide derivatives  | 
| 06/09/1999 | EP0920456A1 Phosgenated oxime resins and their preparation  | 
| 06/09/1999 | EP0920414A1 Matrix metalloproteinase inhibitors  | 
| 06/09/1999 | EP0920312A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents  | 
| 06/09/1999 | EP0920306A2 Chemokine receptor antagonists and methods of use therefor  | 
| 06/09/1999 | CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives  | 
| 06/09/1999 | CN1219130A Composition comprising a nitrone compound for use in treating ocular inflammation  | 
| 06/08/1999 | US5910549 Reacting radically transferrable atoms or groups with a transition metal or transition metal compound and a stable nitroxide radical; long half-life radical initiators of addition polymerization for controlling polydispersity  | 
| 06/08/1999 | US5910499 Leukotriene production inhibiting action and antihistaminic action; oral administration  | 
| 06/08/1999 | US5910496 Synergistic mixture comprising at least one systemic, contact and/or soil fungicides and at least one acrylic acid morpholide derivatives  | 
| 06/08/1999 | CA2089972C Sulfonamidocarboxamides  | 
| 06/04/1999 | CA2255180A1 N-(4-carbamimido-phenyl)-phenylglycinamid derivatives  | 
| 06/03/1999 | WO1999026918A1 Biphenylamidine derivatives  | 
| 06/03/1999 | WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use  | 
| 06/03/1999 | WO1999026584A2 Inhibitors of gap junction communication  | 
| 06/03/1999 | WO1999010312B1 N-alkanoylphenylalanine derivatives  | 
| 06/03/1999 | WO1999005096A3 Urokinase inhibitors  | 
| 06/03/1999 | WO1999002502A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation  | 
| 06/03/1999 | CA2310331A1 Biphenylamidine derivatives  | 
| 06/02/1999 | EP0919550A1 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride  | 
| 06/02/1999 | EP0919542A2 Phthalic acid diamide derivatives, agricultural and horticultural insecticides, and a method for application of the insecticides  | 
| 06/02/1999 | EP0918761A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands  | 
| 06/02/1999 | EP0918514A1 Triaryl methane compounds for sickle cell disease  | 
| 06/02/1999 | EP0748310B1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity  | 
| 06/02/1999 | EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences  | 
| 06/02/1999 | CN1218460A Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma'  | 
| 06/01/1999 | US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism  | 
| 06/01/1999 | US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents  | 
| 05/27/1999 | WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists  | 
| 05/26/1999 | EP0918296A1 Method of virtual retrieval of analogs of lead compounds by constituting potential libraries  | 
| 05/26/1999 | EP0917531A1 New piperazine derivatives and oxydation dyes  | 
| 05/26/1999 | EP0917465A1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing same  | 
| 05/26/1999 | EP0917464A1 Use of amines to produce drugs for preventing tumour cell proliferation  | 
| 05/26/1999 | EP0917462A1 Cell adhesion inhibitors  | 
| 05/26/1999 | EP0686625B1 Anthranilic acid derivative  | 
| 05/25/1999 | US5907039 Amino alcohol derivative and method for preparing the same  | 
| 05/25/1999 | US5906988 Methods of treatment using ranolazine and related piperazine derivatives  | 
| 05/25/1999 | CA1340561C Process for preparing ciprofloxacine  | 
| 05/20/1999 | WO1999024460A2 Dipeptide nitriles  | 
| 05/20/1999 | WO1999024395A1 Compounds which inhibit tryptase activity  | 
| 05/20/1999 | WO1999024393A1 Process to produce oxazolidinones  | 
| 05/20/1999 | CA2634657A1 Process to produce oxazolidinones  | 
| 05/20/1999 | CA2304100A1 Process to produce oxazolidinones  | 
| 05/19/1999 | EP0916675A2 Process for preparing sildenafil  | 
| 05/19/1999 | EP0916652A1 N-Aryl 2-hydroxy alkylamides  | 
| 05/19/1999 | EP0915860A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands  | 
| 05/19/1999 | EP0915859A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands  | 
| 05/19/1999 | EP0915855A1 Novel compounds with analgesic effect  | 
| 05/19/1999 | EP0915841A1 Anilinopeptide derivatives  | 
| 05/19/1999 | EP0915823A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses  | 
| 05/19/1999 | EP0690851B1 Guanidine derivatives useful in therapy  | 
| 05/19/1999 | CN1216977A Alkoxy acetic acid derivatives  | 
| 05/18/1999 | US5905080 Central nervous system, psychological, eating disorders; cognition activators, parkinson*s disease  | 
| 05/18/1999 | US5904818 Process for the regeneration of an aqueous process liquid of the amine-oxide process  | 
| 05/18/1999 | CA2040884C Process for the preparation of 1-(2,3,4-trimethoxybenzyl) piperazine by reductive amination  | 
| 05/18/1999 | CA1340543C Pharmaceutically active compounds  | 
| 05/14/1999 | WO1999023587A2 Method of virtual retrieval of analogs of lead compounds  | 
| 05/14/1999 | WO1999023073A1 Biphenyl derivatives as pharmaceuticals  | 
| 05/14/1999 | WO1999023072A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same  | 
| 05/14/1999 | WO1999023063A1 Substituted anilides  | 
| 05/14/1999 | WO1999001423A8 Glucagon antagonists/inverse agonists  | 
| 05/14/1999 | CA2681877A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same  | 
| 05/14/1999 | CA2308151A1 Biphenyl derivatives as pharmaceuticals  | 
| 05/14/1999 | CA2306822A1 Method of virtual retrieval of analogs of lead compounds  | 
| 05/12/1999 | EP0915086A1 Phenylsulfonamide derivatives  | 
| 05/12/1999 | EP0914605A1 Molecular model for vla-4 inhibitors  | 
| 05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists  | 
| 05/12/1999 | CN1216526A 3,4-disubstituted phenylethanolaminotetra lincarboxamide derivatives  | 
| 05/11/1999 | US5902883 Cyanobutylation of ammonia, alkylamines and hydrazine with 3-pentenenitrile, 4-pentenenitrile or mixtures thereof  | 
| 05/06/1999 | WO1999021850A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d4 receptor subtype ligands  | 
| 05/06/1999 | WO1999021846A1 Cyclopentene derivatives useful as antagonists of the motilin receptor  | 
| 05/06/1999 | WO1999021422A1 Treatment of schizophrenia with ampakines and neuroleptics  | 
| 05/06/1999 | WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors  | 
| 05/06/1999 | WO1998055448A3 Fluoroalkene carboxylic acid derivatives, method for producing said derivatives, and insecticidal agents containing the same  | 
| 05/06/1999 | EP0912534A1 Muscarinic antagonists  | 
| 05/06/1999 | EP0912513A1 Fibrinogen receptor antagonist prodrugs  | 
| 05/06/1999 | EP0912499A1 Pesticides  | 
| 05/06/1999 | EP0912182A1 Fibrinogen receptor antagonist prodrugs  | 
| 05/06/1999 | EP0912175A1 Fibrinogen receptor antagonists  | 
| 05/06/1999 | EP0912170A1 Hiv protease inhibitors useful for the treatment of aids  | 
| 05/06/1999 | EP0750607B1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity  | 
| 05/06/1999 | CA2308057A1 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d4 receptor subtype ligands  | 
| 05/06/1999 | CA2307661A1 Cyclopentene derivatives useful as antagonists of the motilin receptor  | 
| 05/06/1999 | CA2306817A1 Treatment of schizophrenia with ampakines and neuroleptics  | 
| 05/05/1999 | CN1215719A Preparation of amines  | 
| 05/05/1999 | CN1043228C Process for producing halogenophennoxyfatty acid derivs. by selective halogenation and halogenophenoxyfatty acid derivs.  | 
| 05/04/1999 | US5900485 Methods for the manufacture of neofazodone  | 
| 05/04/1999 | US5900415 Dietetic and cardiovascular disorders  | 
| 05/04/1999 | CA2022783C Vicinal di (hetero) alkylene organometalates and processes for the production of amines therewith  |